Evaluation of outcomes and cost-effectiveness of implementing next generation human papillomavirus (HPV) vaccination and associated primary HPV-based cervical cancer screening strategies in Australia

该项目涉及使用模拟建模来预测下一代人乳头瘤病毒（HPV）疫苗的效果，该疫苗将保护免受更多HPV菌株的感染。研究人员将使用从世界各地收集的大型数据集来评估这种新疫苗在澳大利亚和其他主要国家的成本效益，并评估宫颈筛查是否需要在未来改变以解释新疫苗的引入。

This project involves using simulation modelling to predict the effect of the next generation human papillomavirus (HPV) vaccine, which will protect against infection with more strains of HPV. The investigators will use large datasets garnered from around the world to inform the assessment of the cost-effectiveness of this new vaccine in Australia and other key countries, and also to assess whether cervical screening will need to change in the future to account for the introduction of the new vaccine.